<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Nutrition And Food In Health And Disease</title>
<title_fa>1</title_fa>
<short_title>Nutr Food Health Dis</short_title>
<subject>Medical Sciences</subject>
<web_url>http://nfsr.sbmu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2383-0441</journal_id_issn>
<journal_id_issn_online>2383-3009</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/nfsr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2024</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Combination Therapy of Flaxseed and Hesperidin Enhances the Effectiveness of Lifestyle Modification in Metabolic Syndrome: A Randomized Controlled Clinical Trial</title>
	<subject_fa>Nutrition</subject_fa>
	<subject>Nutrition</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;tab-stops:409.5pt&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Background and Objectives: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;Regarding the increasing prevalence of metabolic syndrome (MetS), and its association with non-communicable chronic diseases, providing preventive and therapeutic strategies is a priority. A randomized controlled study was conducted to assess the effects of &lt;a name=&quot;_Hlk530993394&quot;&gt;combination therapy of milled brown flaxseed and hesperidin&lt;/a&gt; during lifestyle intervention on MetS components.&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;tab-stops:409.5pt&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Materials and Methods: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;Forty-eight subjects were randomly assigned to&lt;a name=&quot;_Hlk534899067&quot;&gt; receive lifestyle intervention plus combination therapy of brown flaxseed (30 g milled) and hesperidin (two 500 mg capsules) or lifestyle modification alone for 12 weeks. &lt;/a&gt;MetS was assessed as a primary endpoint. The trial was registered in clinicaltrial.gov:NCT03737422.&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;tab-stops:409.5pt&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;Forty-six percent of patients in the flaxseed-hesperidin group experienced more than three MetS factors improvement from baseline to week 12, while only 17% of patients in the control group fall in this category. A comparison of blood pressure changes throughout the study indicated a greater reduction in blood pressure in the intervention group rather than in the control group (-5.66 &lt;i&gt;vs.&lt;/i&gt; -1.56 mmHg, &lt;i&gt;P&lt;/i&gt; = 0.049). The reduction in plasma glucose (-20.35 &lt;i&gt;vs&lt;/i&gt;. -7.46 mg/dL, &lt;i&gt;P&lt;/i&gt; = 0.007) and triglyceride (-45.3 &lt;i&gt;vs.&lt;/i&gt; -8.39 mg/dL, &lt;i&gt;P&lt;/i&gt; = 0.020) in the flaxseed-hesperidin group was significantly more than the control group after 12 weeks of intervention.&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;tab-stops:409.5pt&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Conclusions: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;Our results indicate that co-administration of flaxseed and hesperidin as an adjunct to lifestyle modification program is more effective than lifestyle modification alone in the treatment of metabolic syndrome.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Metabolic syndrome, Flaxseed, Hesperidin, Lifestyle modification</keyword>
	<start_page>11</start_page>
	<end_page>20</end_page>
	<web_url>http://nfsr.sbmu.ac.ir/browse.php?a_code=A-10-849-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Azita</first_name>
	<middle_name></middle_name>
	<last_name>Hekmatdoost</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>a_hekmat2000@yahoo.com</email>
	<code>10031947532846006617</code>
	<orcid>10031947532846006617</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology, Research Institute Shahid Beheshti University of Medical Science, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Vahideh</first_name>
	<middle_name></middle_name>
	<last_name>Behrouz</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>vahideh.behrouz@gmail.com</email>
	<code>10031947532846006618</code>
	<orcid>10031947532846006618</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Nutrition, School of Public Health, Kerman University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zahra</first_name>
	<middle_name></middle_name>
	<last_name>Yari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>zahrayari_nut@yahoo.com</email>
	<code>10031947532846006619</code>
	<orcid>10031947532846006619</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Nutrition Research, National Nutrition and Food Technology Research Institute and Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
